XM does not provide services to residents of the United States of America.
A
A

Almirall

News

Ebglyss Provided Sustained Disease Control For Up To 3 Years In Over 80% Of Adults And Adolescents With Atopic Dermatitis - Almirall

BRIEF-Ebglyss Provided Sustained Disease Control For Up To 3 Years In Over 80% Of Adults And Adolescents With Atopic Dermatitis - Almirall Sept 25 (Reuters) - Almirall SA ALM.MC : EBGLYSS PROVIDED SUSTAINED DISEASE CONTROL FOR UP TO 3 YEARS IN OVER 80% OF ADULTS AND ADOLESCENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS SAFETY PROFILE AT THREE YEARS
A

Almirall jumps after H1 profit beat

BUZZ-Almirall jumps after H1 profit beat ** Shares in Almirall ALM.MC rise around 4%, topping the Madrid General Index .SMSI , after the Spanish drugmaker said its H1 net profit rose 28% to 15.4 million euros ($16.76 million) year-on-year ** "H1 profits just ahead," Jefferies says after forecasting a profit of 11.6 million euros; consensus expected
A

Spanish stocks - Factors to watch on July 22

Spanish stocks - Factors to watch on July 22 July 22 (Reuters) - The following Spanish stocks may be affected by newspaper reports and other factors on Monday. Reuters has not verified the newspaper reports, and cannot vouch for their accuracy: GRIFOLS GRLS.MC The Spanish drugmaker said on Friday it had appointed Morgan Stanley and Goldman Sachs as financial advisors for potential Brookfield's takeover bid.
A
A
G
N
M
S

Almirall H1 Net Profit Up At 15.4 Mln Euros YoY

BRIEF-Almirall H1 Net Profit Up At 15.4 Mln Euros YoY July 22 (Reuters) - Almirall SA ALM.MC : H1 NET PROFIT 15.4 MILLION EUROS VERSUS 12.0 MILLION EUROS YEAR AGO Source text for Eikon: ID:nCNM33ZxdN Further company coverage: ALM.MC (Gdansk Newsroom)
A

Almirall Reiterates 2024 Guidance

BRIEF-Almirall Reiterates 2024 Guidance July 22 (Reuters) - Almirall SA ALM.MC : REITERATES 2024 GUIDANCE Source text for Eikon: ID:nCNM2szVD4 Further company coverage: ALM.MC (Gdansk Newsroom)
A

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.